Monday, January 24, 2022

Omicron May Not Evade All Monoclonal Antibodies, Study Suggests

The Omicron variant of coronavirus may evade several, but not all, monoclonal antibodies used clinically to prevent patients from developing severe COVID-19, according to a laboratory study.

from NDTV News - World-news https://ift.tt/33LnQKT

No comments:

Post a Comment

Microsoft CEO Satya Nadella Says AI Reshaping Innovation Across Sectors

Microsoft CEO Satya Nadella said the world is entering a new era where the "frontier of what is possible" is rapidly expanding, dr...